-
Taxonomy & unit
-
us-gaap: USD and USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Chemours Co quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2013 to 2023.
- Chemours Co Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $15 M, a 46.4% decline year-over-year.
- Chemours Co Income Tax Expense (Benefit) for the twelve months ending March 31, 2024 was -$94 M, a 165% decline year-over-year.
- Chemours Co annual Income Tax Expense (Benefit) for 2023 was -$81 M, a 150% decline from 2022.
- Chemours Co annual Income Tax Expense (Benefit) for 2022 was $163 M, a 140% increase from 2021.
- Chemours Co annual Income Tax Expense (Benefit) for 2021 was $68 M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual Data (USD)